Home
Scholarly Works
Dulaglutide reduces HbA(1c) irrespective of...
Conference

Dulaglutide reduces HbA(1c) irrespective of antihyperglycaemic agents, duration of diabetes, BMI and weight loss: a post hoc analysis from the REWIND trial

Authors

Xavier D; Kwan A; Gerstein H; Basile J; Maldonado JM; Raha S; Konig M

Volume

63

Pagination

pp. S288-S288

Publisher

SPRINGER

Publication Date

September 1, 2020

Name of conference

56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)

Conference place

ELECTR NETWORK

Conference start date

September 21, 2020

Conference end date

September 25, 2020

Conference proceedings

DIABETOLOGIA

Issue

SUPPL 1

ISSN

0012-186X

Labels

Contact the Experts team